SHARE
Ankylosing Spondylitis Market

Ankylosing Spondylitis - Global Market Outlook (2019 -2027)

4.2 (51 reviews)
Published: September 2020 ID: SMRC19958
4.2 (51 reviews)
Published: September 2020 ID: SMRC19958

This report covers the impact of COVID-19 on this global market

According to Stratistics MRC, the Global Ankylosing Spondylitis Market is accounted for $4.38 billion in 2019 and is expected to reach $9.59 billion by 2027 growing at a CAGR of 10.3% during the forecast period. Rising prevalence of Ankylosing Spondylitis, growing awareness about diagnostics and treatments for the disease. Additionally, government initiatives and getting better healthcare infrastructure are the major factors propelling the market growth. However, the huge cost of treatment and lack of skilled surgeons and physiotherapists are hampering the market growth.
 

Ankylosing Spondylitis - Global Market Outlook (2019 -2027)


Ankylosing spondylitis is a chronic inflammatory disease that affects the spine. It is a kind of arthritis, in which spine bones grow or fuse together, causing the spine to turn into rigid. Symptoms of ankylosing spondylitis comprise pain and stiffness from the neck to the lower back, bony fusion, and pain in the ligaments and tendons. These symptomatic changes may be mild or severe, and may lead to a stooped-over posture.

Based on the drugs, the humira segment is going to have a lucrative growth during the forecast period due to it’s a prescription medicine used to reduce the signs and symptoms of ankylosing spondylitis in adults. Humira can help to reduce the back pain, stiffness of AS, low cost and high efficiency.

By geography, North America is going to have a lucrative growth during the forecast period due to the more prevalence of the disease and amplified adoption of ankylosing spondylitis treatment options in the region. In addition, technological developments are driving ankylosing spondylitis treatment in this region.

Some of the key players profiled in the Ankylosing Spondylitis Market include Abbvie, Amgen, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Celltrion, Eisai, Eli Lilly and Company, F. Hoffmann-La Roche, Janssen Pharmaceuticals, Johnson & Johnson Services, Inc, Merck & Co, Novartis AG, Pfizer, Regeneron Pharmaceuticals, Sanofi, Shanghai Pharmaceuticals and UCB, Inc.

Molecule Types Covered:
• Biologics
• Biosimilars
• Small Molecules

Route of Administrations Covered:
• Oral
• Parenteral

Dosage Forms Covered:
• Liquid
• Solid

Drugs Covered:
• Cimzia
• Cosentyx
• Enbrel
• Humira
• Remicade
• Simponi

Drug Types Covered:
• Anti-Inflammatory Drugs
• COX Inhibitors
• Disease-Modifying Anitrheumatic Drugs (DMARDs)
• Immunosuppressive Drugs
• JAK Inhibitors
• Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
• Steroids
• TNF Inhibitors
• IL-17 Inhibitors

Treatment Types Covered:
• Medication
• Surgery
• Therapy

Applications Covered:
• Adults
• Juveniles

End Users Covered:
• Hospital
• Care Home
• Clinic

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan       
o China       
o India       
o Australia 
o New Zealand
o South Korea
o Rest of Asia Pacific   
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2018, 2019 2020, 2024, and 2027
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

1 Executive Summary       
         
2 Preface       
 
 2.1 Abstract       
 2.2 Stake Holders      
 2.3 Research Scope      
 2.4 Research Methodology     
  2.4.1 Data Mining     
  2.4.2 Data Analysis     
  2.4.3 Data Validation     
  2.4.4 Research Approach     
 2.5 Research Sources      
  2.5.1 Primary Research Sources    
  2.5.2 Secondary Research Sources    
  2.5.3 Assumptions     
         
3 Market Trend Analysis      
 3.1 Introduction      
 3.2 Drivers       
 3.3 Restraints      
 3.4 Opportunities      
 3.5 Threats       
 3.6 Application Analysis     
 3.7 End User Analysis      
 3.8 Emerging Markets      
 3.9 Impact of Covid-19      
         
4 Porters Five Force Analysis      
 4.1 Bargaining power of suppliers     
 4.2 Bargaining power of buyers     
 4.3 Threat of substitutes      
 4.4 Threat of new entrants     
 4.5 Competitive rivalry      
         
5 Global Ankylosing Spondylitis Market, By Molecule Type   
 5.1 Introduction      
 5.2 Biologics       
 5.3 Biosimilars      
 5.4 Small Molecules      
         
6 Global Ankylosing Spondylitis Market, By Route of Administration  
 6.1 Introduction      
 6.2 Oral       
 6.3 Parenteral      
         
7 Global Ankylosing Spondylitis Market, By Dosage Form   
 7.1 Introduction      
 7.2 Liquid       
 7.3 Solid       
         
8 Global Ankylosing Spondylitis Market, By Drug    
 8.1 Introduction      
 8.2 Cimzia       
 8.3 Cosentyx       
 8.4 Enbrel       
 8.5 Humira       
 8.6 Remicade      
 8.7 Simponi       
         
9 Global Ankylosing Spondylitis Market, By Drug Type   
 9.1 Introduction      
 9.2 Anti-Inflammatory Drugs     
 9.3 COX Inhibitors      
 9.4 Disease-Modifying Anitrheumatic Drugs (DMARDs)   
 9.5 Immunosuppressive Drugs     
 9.6 JAK Inhibitors      
 9.7 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)   
 9.8 Steroids       
 9.9 TNF Inhibitors      
 9.10 IL-17 Inhibitors      
         
10 Global Ankylosing Spondylitis Market, By Treatment Type   
 10.1 Introduction      
 10.2 Medication      
 10.3 Surgery       
 10.4 Therapy       
         
11 Global Ankylosing Spondylitis Market, By Application   
 11.1 Introduction      
 11.2 Adults       
 11.3 Juveniles       
         
12 Global Ankylosing Spondylitis Market, By End User    
 12.1 Introduction      
 12.2 Hospital       
 12.3 Care Home      
 12.4 Clinic       
         
13 Global Ankylosing Spondylitis Market, By Geography   
 13.1 Introduction      
 13.2 North America      
  13.2.1 US      
  13.2.2 Canada      
  13.2.3 Mexico      
 13.3 Europe       
  13.3.1 Germany      
  13.3.2 UK      
  13.3.3 Italy      
  13.3.4 France      
  13.3.5 Spain      
  13.3.6 Rest of Europe     
 13.4 Asia Pacific      
  13.4.1 Japan      
  13.4.2 China      
  13.4.3 India      
  13.4.4 Australia      
  13.4.5 New Zealand     
  13.4.6 South Korea     
  13.4.7 Rest of Asia Pacific     
 13.5 South America      
  13.5.1 Argentina     
  13.5.2 Brazil      
  13.5.3 Chile      
  13.5.4 Rest of South America    
 13.6 Middle East & Africa     
  13.6.1 Saudi Arabia     
  13.6.2 UAE      
  13.6.3 Qatar      
  13.6.4 South Africa     
  13.6.5 Rest of Middle East & Africa    
         
14 Key Developments       
 14.1 Agreements, Partnerships, Collaborations and Joint Ventures  
 14.2 Acquisitions & Mergers     
 14.3 New Product Launch     
 14.4 Expansions      
 14.5 Other Key Strategies     
         
15 Company Profiling       
 15.1 Abbvie       
 15.2 Amgen       
 15.3 Boehringer Ingelheim     
 15.4 Bristol-Myers Squibb     
 15.5 Celgene       
 15.6 Celltrion       
 15.7 Eisai       
 15.8 Eli Lilly and Company     
 15.9 F. Hoffmann-La Roche     
 15.10 Janssen Pharmaceuticals     
 15.11 Johnson & Johnson Services, Inc    
 15.12 Merck & Co      
 15.13 Novartis AG      
 15.14 Pfizer       
 15.15 Regeneron Pharmaceuticals     
 15.16 Sanofi       
 15.17 Shanghai Pharmaceuticals     
 15.18 UCB, Inc      


List of Tables        
1 Global Ankylosing Spondylitis Market Outlook, By Region (2018-2027) ($MN) 
2 Global Ankylosing Spondylitis Market Outlook, By Molecule Type (2018-2027) ($MN)
3 Global Ankylosing Spondylitis Market Outlook, By Biologics (2018-2027) ($MN) 
4 Global Ankylosing Spondylitis Market Outlook, By Biosimilars (2018-2027) ($MN) 
5 Global Ankylosing Spondylitis Market Outlook, By Small Molecules (2018-2027) ($MN)
6 Global Ankylosing Spondylitis Market Outlook, By Route of Administration (2018-2027) ($MN)
7 Global Ankylosing Spondylitis Market Outlook, By Oral (2018-2027) ($MN) 
8 Global Ankylosing Spondylitis Market Outlook, By Parenteral (2018-2027) ($MN) 
9 Global Ankylosing Spondylitis Market Outlook, By Dosage Form (2018-2027) ($MN) 
10 Global Ankylosing Spondylitis Market Outlook, By Liquid (2018-2027) ($MN) 
11 Global Ankylosing Spondylitis Market Outlook, By Solid (2018-2027) ($MN) 
12 Global Ankylosing Spondylitis Market Outlook, By Drug (2018-2027) ($MN) 
13 Global Ankylosing Spondylitis Market Outlook, By Cimzia (2018-2027) ($MN) 
14 Global Ankylosing Spondylitis Market Outlook, By Cosentyx (2018-2027) ($MN) 
15 Global Ankylosing Spondylitis Market Outlook, By Enbrel (2018-2027) ($MN) 
16 Global Ankylosing Spondylitis Market Outlook, By Humira (2018-2027) ($MN) 
17 Global Ankylosing Spondylitis Market Outlook, By Remicade (2018-2027) ($MN) 
18 Global Ankylosing Spondylitis Market Outlook, By Simponi (2018-2027) ($MN) 
19 Global Ankylosing Spondylitis Market Outlook, By Drug Type (2018-2027) ($MN) 
20 Global Ankylosing Spondylitis Market Outlook, By Anti-Inflammatory Drugs (2018-2027) ($MN)
21 Global Ankylosing Spondylitis Market Outlook, By COX Inhibitors (2018-2027) ($MN)
22 Global Ankylosing Spondylitis Market Outlook, By Disease-Modifying Anitrheumatic Drugs (DMARDs) (2018-2027) ($MN)
23 Global Ankylosing Spondylitis Market Outlook, By Immunosuppressive Drugs (2018-2027) ($MN)
24 Global Ankylosing Spondylitis Market Outlook, By JAK Inhibitors (2018-2027) ($MN)
25 Global Ankylosing Spondylitis Market Outlook, By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) (2018-2027) ($MN)
26 Global Ankylosing Spondylitis Market Outlook, By Steroids (2018-2027) ($MN) 
27 Global Ankylosing Spondylitis Market Outlook, By TNF Inhibitors (2018-2027) ($MN)
28 Global Ankylosing Spondylitis Market Outlook, By IL-17 Inhibitors (2018-2027) ($MN)
29 Global Ankylosing Spondylitis Market Outlook, By Treatment Type (2018-2027) ($MN)
30 Global Ankylosing Spondylitis Market Outlook, By Medication (2018-2027) ($MN) 
31 Global Ankylosing Spondylitis Market Outlook, By Surgery (2018-2027) ($MN) 
32 Global Ankylosing Spondylitis Market Outlook, By Therapy (2018-2027) ($MN) 
33 Global Ankylosing Spondylitis Market Outlook, By Application (2018-2027) ($MN) 
34 Global Ankylosing Spondylitis Market Outlook, By Adults (2018-2027) ($MN) 
35 Global Ankylosing Spondylitis Market Outlook, By Juveniles (2018-2027) ($MN) 
36 Global Ankylosing Spondylitis Market Outlook, By End User (2018-2027) ($MN) 
37 Global Ankylosing Spondylitis Market Outlook, By Hospital (2018-2027) ($MN) 
38 Global Ankylosing Spondylitis Market Outlook, By Care Home (2018-2027) ($MN) 
39 Global Ankylosing Spondylitis Market Outlook, By Clinic (2018-2027) ($MN) 
         
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.

In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.

Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.

All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

We have 3 different licensing options available in electronic format.

  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.

All our reports are typically be emailed to you as an attachment.

To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.

We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

Select License Type

Allows one person to have access to the ordered product.The ordered product cannot be distributed to anyone else.
Allows the ordered product to be shared among a maximum of 5 people within your organisation.
Allows the product to be shared among all employees of your organisation at one particular location.
Allows the product to be shared among all employees of your organisation regardless of their geographical location.

WHY CHOOSE US ?

Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials